You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 10,588,895


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,588,895
Patent landscape, scope, and claims:
Title:Quinuclidine derivatives and medicinal compositions containing the same
Abstract: Provided is a method for treating chronic obstructive pulmonary disease or chronic bronchitis, or inhibiting bronchospasm, which method comprises use of a powder inhaler to administer to a human patient in need of such treatment an effective amount of a powder inhalant, wherein the powder inhalant comprises 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicy- clo[2.2.2]octane bromide.
Inventor(s): Fernandez Forner; Maria Dolors (Barcelona, ES), Prat Quinones; Maria (Barcelona, ES), Buil Albero; Maria Antonia (Barcelona, ES)
Assignee: ALMIRALL, S.A. (Barcelona, ES)
Application Number:16/045,333
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,588,895

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,588,895

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Spain9901580Jul 14, 1999

International Family Members for US Patent 10,588,895

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1200431 ⤷  Subscribe C300573 Netherlands ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe CA 2013 00002 Denmark ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe PA2013001 Lithuania ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe 92132 Luxembourg ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe 2013/002 Ireland ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe 13C0001 France ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.